ad image

GMP

1 / 2
Bio-Techne Corporation
Announcement

Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System

Bio-Techne Corporation

PR-02-25-NI-17Feb 19, 2025
Fast Path to Market: Going from GMP1 to PPQ in Just 12 Months
PPQ

Fast Path to Market: Going from GMP1 to PPQ in Just 12 Months

Jessica Feldman, Ph.D.; Henning Gerschewski

Rentschler Biopharma SE

PAO-10-24-CL-12Dec 02, 2024
Reach the Patient Quicker with GBI’s Manufacturing Solutions
Clinical and Commercial Manufacturing

Reach the Patient Quicker with GBI’s Manufacturing Solutions

Muctarr Sesay, Ph.D.

GBI

PAO-08-23-CL-02Aug 08, 2023
Richter BioLogics
New Facility Milestone

Richter-Helm's Biomanufacturing Facility Expansion Progress: Inauguration of New Office Building

Richter BioLogics

PR-M06-23-03May 31, 2023
The Value of a Custom Lipid Solutions Provider for mRNA Delivery
Custom Lipid Nanoparticle Development

The Value of a Custom Lipid Solutions Provider for mRNA Delivery

Lauren Longobardi, Ph.D.; Rima Jaber, Ph.D.; Sebastian Detlefsen, Dr.-Ing.

Evonik

PAO-11-022-CL-17Jan 05, 2023
Quality in Equals Quality Out in mRNA Manufacturing
Quality in mRNA Manufacturing

Quality in Equals Quality Out in mRNA Manufacturing

Judith McCorry

Vernal Biosciences

PAO-10-022-CL-08Nov 08, 2022
A PODular Therapies-as-a-Service Approach To Fundamentally Change the CAR-T Cell Therapy Landscape
Cell Therapy

A PODular Therapies-as-a-Service Approach To Fundamentally Change the CAR-T Cell Therapy Landscape

David Alvaro, Ph.D.

Pharma's Almanac

PAO-05-022-CL-05May 31, 2022
Exothera
GMP Certification

GMP Certification for Exothera Further Extends its Viral Vector Manufacturing Capacity

Exothera

PR-M03-22-10Mar 23, 2022
Intravacc
GMP

Intravacc Announces the Publication of a GMP Process for a Semi-Synthetic Shigella Glycoconjugate Vaccine Candidate from Institut Pasteur

Intravacc

PR-M03-22-09Mar 22, 2022
Will Remote Pharma GMP Auditing Continue Post-COVID?
Remote Auditing

Will Remote Pharma GMP Auditing Continue Post-COVID?

Alasdair Leckie

PAO-02-022-CL-21Mar 16, 2022
Andelyn Biosciences
Expansion

FDA Accepts GMP Plasmid DMF and Capacity Expansion Enabling Andelyn Biosciences to Offer Faster Gene Therapy Development

Andelyn Biosciences

PR-M01-22-10Jan 13, 2022
Innovative Strategies to Maintain Product Integrity in Biologic and Biosimilar Clinical Studies
Clinical Trial Logistics

Innovative Strategies to Maintain Product Integrity in Biologic and Biosimilar Clinical Studies

Mark Woolf

Catalent

PAO-03-21-CL-06Mar 22, 2021
Takara Bio Inc
Immunotherapy

Takara Bio submits Drug Master File to US FDA for RetroNectin® GMP grade (liquid format)

Takara Bio Inc

PR-M04-19-NI-048Apr 15, 2019
Adjusting Internal Structure to Better Meet Demands of Unmet Business
Commercialization

Adjusting Internal Structure to Better Meet Demands of Unmet Business

James E. Gregory

UPM Pharmaceuticals

PAP-Q1-2019-CL-009Apr 12, 2019
WuXi Biologics
GMP

WuXi Biologics Receives EMA GMP Certificates

WuXi Biologics

PR-M03-19-NI-061Mar 22, 2019
Speed and Customized Support from Gene to GMP Manufacturing
Lifecycle Support

Speed and Customized Support from Gene to GMP Manufacturing

Giedrius Žunda

Northway Biotechpharma

PAP-Q1-2019-CL-026Mar 12, 2019
Kaneka
Continuous Manufacturing

Kaneka Officially Starts Continuous Manufacturing Under GMP

Kaneka

PR-M09-18-NI-022Sep 10, 2018
State-of-the-Art Biologics Manufacturing in an Unexpected Location
GMP

State-of-the-Art Biologics Manufacturing in an Unexpected Location

Vladas Algirdas Bumelis

Northway Biotechpharma

PAP-Q2-18-CL-010May 29, 2018
Abzena’s New GMP Manufacturing Suite Expands ADC Chemistry Solutions at Bristol Site
Expanded Capacity

Abzena’s New GMP Manufacturing Suite Expands ADC Chemistry Solutions at Bristol Site

Marc Technow

Nice Insight

PR-M03-18-NI-105Mar 30, 2018
EMA, FDA Move Forward with Mutual Recognition of Inspections
FDA

EMA, FDA Move Forward with Mutual Recognition of Inspections

Nigel Walker

Nice Insight

PAO-M11-17-NI-017Nov 10, 2017
1 / 2